On Monday, President Biden announced his plans to expand “Cancer Moonshot” plan, an initiative aiming to “end cancer as we know it.”
The initiative ensures there is funding, drug development, and research dedicated to preventing cancer deaths. Biden’s goal is to cut US cancer fatalities by 50% over the next 25 years and to improve the lives of caregivers and those diagnosed with cancer.
Biden also announced that Renee Wegrzyn will be the inaugural director of the Advanced Research Projects Agency for Health (ARPA-H).
“Under Dr. Wegrzyn’s leadership, ARPA-H will support programs and projects that undertake challenges ranging from the molecular to the societal, with the potential to transform entire areas of medicine and health in order to prevent, detect, and treat some of the most complex diseases such as Alzheimer’s, diabetes, and cancer, providing benefits for all Americans,” the White House said.
Funding the moonshot initiative is only one piece of Biden’s cancer-ending goals. In February, the President established the “Cancer Cabinet,” which lays out the White House’s cancer-cutting goals across eight areas. These goals include lowering the costs of prescription drugs for cancer patients, launching multi-cancer detection, and using a Department of Defense program to understand the impact of toxic exposure on military members.
Biden also signed an executive order that will boost biotechnology and biomanufacturing so that cutting-edge technology can be developed to fight cancer.